Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel agents for chronic lymphocytic leukemia
Mei‐Hwan Wu, Akintunde Akinleye, Xiongpeng Zhu
Journal of Hematology & Oncology (2013) Vol. 6, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akintunde Akinleye, Parthu Avvaru, Muhammad Furqan, et al.
Journal of Hematology & Oncology (2013) Vol. 6, Iss. 1
Open Access | Times Cited: 239
Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Damanpreet Kaur Lang, Rajwinder Kaur, Rashmi Arora, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 20, Iss. 18, pp. 2150-2168
Closed Access | Times Cited: 176
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
Kaushal Parikh, Shundong Cang, Arunabh Sekhri, et al.
Journal of Hematology & Oncology (2014) Vol. 7, Iss. 1
Open Access | Times Cited: 133
Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria
Ahmad Salimi, Mehryar Habibi Roudkenar, Leila Sadeghi, et al.
Redox Biology (2015) Vol. 6, pp. 461-471
Open Access | Times Cited: 94
Ibrutinib for B cell malignancies
Aileen Novero, Pavan Mahendra Ravella, Yamei Chen, et al.
Experimental Hematology and Oncology (2014) Vol. 3, Iss. 1
Open Access | Times Cited: 75
Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia
Daniela Kern, Gerhard Regl, Sebastian W. Hofbauer, et al.
Oncogene (2015) Vol. 34, Iss. 42, pp. 5341-5351
Open Access | Times Cited: 57
Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway
Mahmoud Alhosin, Antonio J. León‐González, Israa Dandache, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 52
Practices in Molecular Docking and Structure-Based Virtual Screening
Ricardo Nascimento dos Santos, Leonardo L. G. Ferreira, Adriano D. Andricopulo
Methods in molecular biology (2018), pp. 31-50
Closed Access | Times Cited: 52
Immunotherapy in chronic lymphocytic leukemia: advances and challenges
Pan Gao, Yang Zhang, Jun Ma, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Organocatalysed synthesis of N-(4-oxo-2-phenyl-1,2-dihydroquinazolin-3(4H)-yl)isonicotinamide: computational, electrochemical, drug-likeness and antimicrobial studies
Radhika Mane, Deepak A. Yaraguppi, Zabin K. Bagewadi, et al.
3 Biotech (2025) Vol. 15, Iss. 1
Closed Access
Importance of quinazoline and quinazolinone derivatives in medicinal chemistry
Mahesh P. Bhat, S. L. Belagali, S Mamatha, et al.
Studies in natural products chemistry (2021), pp. 185-219
Closed Access | Times Cited: 25
Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia
R. Kanti
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole
Federica Frezzato, Valentina Trimarco, Veronica Martini, et al.
British Journal of Haematology (2014) Vol. 165, Iss. 5, pp. 659-672
Closed Access | Times Cited: 25
Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib
Davood Bashash, Ava Safaroghli‐Azar, Maryam Dadashi, et al.
The International Journal of Biochemistry & Cell Biology (2017) Vol. 85, pp. 149-158
Closed Access | Times Cited: 21
Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells
Cristina Arimany-Nardí, Arnau Montraveta, Eriong Lee‐Vergés, et al.
The Pharmacogenomics Journal (2015) Vol. 15, Iss. 4, pp. 363-371
Closed Access | Times Cited: 18
Ibrutinib and Indolent B-Cell Lymphomas
Akintunde Akinleye, Muhammad Furqan, Oluwaseyi Adekunle
Clinical Lymphoma Myeloma & Leukemia (2013) Vol. 14, Iss. 4, pp. 253-260
Closed Access | Times Cited: 19
Curcumin in chronic lymphocytic leukemia – A review
Vagish Kumar L Shanbhag
Asian Pacific Journal of Tropical Biomedicine (2017) Vol. 7, Iss. 6, pp. 505-512
Open Access | Times Cited: 17
Clinical features and the molecular biomarkers of olfactory neuroblastoma
Xiaolin Peng, Yao Liu, Xin Peng, et al.
Pathology - Research and Practice (2018) Vol. 214, Iss. 8, pp. 1123-1129
Closed Access | Times Cited: 17
Drugs That Inhibit Signaling Pathways for Tumor Cell Growth and Proliferation
Carmen Avendaño, J. Carlos Menéndez
Elsevier eBooks (2015), pp. 391-491
Closed Access | Times Cited: 13
Efficient Phosphorus-Free Chlorination of Hydroxy Aza-Arenes and Their Application in One-Pot Pharmaceutical Synthesis
Jian Wang, Yanhui Li, Song-Cheng Pan, et al.
Organic Process Research & Development (2020) Vol. 24, Iss. 2, pp. 146-153
Closed Access | Times Cited: 12
Ibrutinib: from bench side to clinical implications
Davide Grisafi, Alessandra Maestro, Camilla Grumi, et al.
Medical Oncology (2015) Vol. 32, Iss. 9
Closed Access | Times Cited: 10
Determination of comprehensive in silico determinants as a strategy for identification of novel PI3Kα inhibitors
Shubham Srivastava, Ajeesh Vengamthodi, Inderpal Singh, et al.
Structural Chemistry (2019) Vol. 30, Iss. 5, pp. 1761-1778
Closed Access | Times Cited: 5
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock
Muhammad Furqan, Chen Yamei, Akintunde Akinleye, et al.
Frontiers of Medicine (2014) Vol. 8, Iss. 2, pp. 254-258
Closed Access | Times Cited: 3
Facile synthesis of aryl and benzyl substituted 2-methylquinazolin-4(3H)-one ring by microfluidic flow reaction chemistry
Dongwook Wi, Jesus Campagna, Whitaker Cohn, et al.
Tetrahedron Letters (2024) Vol. 138, pp. 154961-154961
Open Access
Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy
Heather H. Cheng, Colleen Soleau, Evan Y. Yu
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top